IMNN vs RARE · $9.2M cap vs rev $350.0M
Imunon Inc (IMNN) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Imunon Inc (IMNN) is a biotechnology company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
IMNN does not have a complete income-statement cache yet.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
IMNN currently screens at market cap $9.2M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the IMNN and RARE stock pages for the full models.
Not investment advice.